Lepeytre Fanny, Dahhou Mourad, Zhang Xun, Boucquemont Julie, Sapir-Pichhadze Ruth, Cardinal Heloise, Foster Bethany J
Department of Medicine, Nephrology Division and Research Center, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada.
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
J Am Soc Nephrol. 2017 Oct;28(10):3014-3023. doi: 10.1681/ASN.2016121380. Epub 2017 Jun 7.
Prior studies of sex differences in kidney graft survival showed conflicting results. We hypothesized that the association between recipient sex and kidney graft failure risk differs by recipient age and donor sex. We evaluated 159,417 patients recorded in the Scientific Registry of Transplant Recipients database who received a first deceased-donor kidney transplant (1995-2013). We used time-varying Cox models to estimate the association between recipient sex and death-censored graft failure. Models, stratified on donor sex and adjusted for potential confounders, included a recipient sex by current age interaction term. Among recipients of male donors, females of all ages had significantly higher graft failure risks than males (adjusted hazard ratios 0-14 years: 1.51 [95% confidence intervals 1.19 to 1.90]; 15-24 years: 1.37 [1.18 to 1.59]; 25-44 years: 1.14 [1.03 to 1.26]; 45 years: 1.05 [1.01 to 1.09]). Among recipients of female-donor grafts, only female recipients aged 15-24 years had a significantly higher graft failure risk than their male counterparts had (1.28 [1.06 to 1.53]). Indeed, female recipients aged ≥45 years had a significantly lower graft failure risk than their male counterparts had (0.95 [0.91 to 0.99]). These observations might be explained by the combined influence of several factors, including recognition of sex-determined minor histocompatibility antigens, influence of sex hormones on immune activation, sex- and age-related differences in medication adherence, and sex-related differences in body size. Additional studies should determine whether sex- and age-specific immunosuppression strategies are warranted for kidney graft recipients.
先前关于肾移植存活性别差异的研究结果相互矛盾。我们假设受者性别与肾移植失败风险之间的关联因受者年龄和供者性别而异。我们评估了移植受者科学登记数据库中记录的159417例接受首次尸体供肾移植的患者(1995 - 2013年)。我们使用时变Cox模型来估计受者性别与死亡删失的移植失败之间的关联。按供者性别分层并针对潜在混杂因素进行调整的模型包括受者性别与当前年龄的交互项。在男性供者的受者中,各年龄段的女性移植失败风险均显著高于男性(调整后的风险比0 - 14岁:1.51 [95%置信区间1.19至1.90];15 - 24岁:1.37 [1.18至1.59];25 - 44岁:1.14 [1.03至1.26];45岁及以上:1.05 [1.01至1.09])。在女性供者移植的受者中,只有15 - 24岁的女性受者移植失败风险显著高于男性受者(1.28 [1.06至1.53])。实际上,年龄≥45岁的女性受者移植失败风险显著低于男性受者(0.95 [0.91至0.99])。这些观察结果可能由多种因素的综合影响来解释,包括对性别决定的次要组织相容性抗原的识别、性激素对免疫激活的影响、药物依从性方面的性别和年龄差异以及体型方面的性别差异。进一步的研究应确定肾移植受者是否需要针对性别和年龄的免疫抑制策略。